Literature DB >> 21044844

Highly active antimycobacterial derivatives of benzoxazine.

Eva Petrlíková1, Karel Waisser, Hana Divišová, Petra Husáková, Petra Vrabcová, Jiří Kuneš, Karel Kolář, Jiřina Stolaříková.   

Abstract

New 3-(4-alkylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dithiones were synthesized. The compounds were tested for in vitro antimycobacterial activity against Mycobacterium tuberculosis, Mycobacterium avium and two strains of Mycobacterium kansasii. The antimycobacterial activity increased with the replacement of the carbonyl group by the thiocarbonyl group in the starting 3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-diones. The most active derivatives were more active than isonicotinhydrazide (INH). Free-Wilson analysis was also carried out and the activity contribution was examined.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21044844     DOI: 10.1016/j.bmc.2010.10.017

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Redox-neutral α-oxygenation of amines: reaction development and elucidation of the mechanism.

Authors:  Matthew T Richers; Martin Breugst; Alena Yu Platonova; Anja Ullrich; Arne Dieckmann; K N Houk; Daniel Seidel
Journal:  J Am Chem Soc       Date:  2014-04-14       Impact factor: 15.419

2.  Synthesis and fungicidal activity of novel 2,3-disubstituted-1,3-benzoxazines.

Authors:  Zilong Tang; Zhonghua Zhu; Zanwen Xia; Hanwen Liu; Jinwen Chen; Wenjing Xiao; Xiaoming Ou
Journal:  Molecules       Date:  2012-07-06       Impact factor: 4.411

3.  Synthesis of 3,5-isoxazolidinediones and 1H-2,3-benzoxazine-1,4(3H)-diones from aliphatic oximes and dicarboxylic acid chlorides.

Authors:  Robert A Izydore; Joseph T Jones; Benjamin Mogesa; Ira N Swain; Ronda G Davis-Ward; Dwayne L Daniels; Felicia Frazier Kpakima; Sharnelle T Spaulding-Phifer
Journal:  J Org Chem       Date:  2014-03-21       Impact factor: 4.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.